Apyx Medical Corp (APYX): יחס שווי פעילות לרווח לפני ריבית, מסים ופחת

Apyx Medical (APYX) maintains high operational efficiency through the diversification of logistics hubs used in the production of plasma scalpels. Export stability is further bolstered by a neutral geopolitical environment within the medical sector. Price visualization on GURU.Markets shows that EV/EBITDA stands at 0.00. Business development relies on a staff of specialized engineers attracted by the uniqueness of J-Plasma technology and a competitive incentive system.

Sales growth for Apyx Medical consumables depends directly on the integration of plasma technologies into aesthetic surgery and the expansion of FDA approvals. An analysis of the EV/EBITDA multiple, accounting for net debt, allows for an assessment of the total enterprise value relative to operating profit, neutralizing the impact of taxes and debt load to determine the asset's objective market value.